The following presentations were given at the 2016 meeting. Visit the
ECD Global Alliance YouTube channel for all published ECD related videos.
| Presenter |
Presentation Slides |
Videos |
| Corrado Campochiaro, MD |
Management of ECD Symptoms and Side Effects of Treatments |
Management of ECD Symptoms and Side Effects of Treatments |
| Giulio Cavalli, MD |
Adult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester Disease |
Adult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester Disease |
| Carine Courtillot, MD |
Endocrine manifestations in Erdheim-Chester disease |
Endocrine manifestations in Erdheim-Chester disease |
| Benjamin Durham, MD |
Insights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine Models |
Insights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine Models |
| Marina Ferrarini, MD |
Tailoring Treatment for Erdheim-Chester Disease: Focus on ECD |
Tailoring Treatment for Erdheim-Chester Disease: Focus on ECD |
| Ronald Go, MD |
Efficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD) |
Efficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD) |
| Filip Janku, MD, PhD |
Encouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation statusClinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester Disease |
Encouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation statusClinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester Disease |
| Javier Martin, MD, PhD |
Future Genetic Studies in Erdheim-Chester disease – GWAS Study |
Future Genetic Studies in Erdheim-Chester disease – GWAS Study |
| Kenneth McClain, MD, PhD |
Elevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD? |
Elevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD? |
| Augusto Vaglio, MD, PhD |
MRI evidence of cardiac involvement in Erdheim-Chester disease |
MRI evidence of cardiac involvement in Erdheim-Chester disease |
rare connect
